HealthcarePharma / biotechFinancial reportingBoard / governance
Financial Discipline in Pre-Revenue Biotech
December 4, 202443 min
Show Notes
Elena Vasquez manages the runway for a clinical-stage biotech through multiple funding cycles. She talks through the reporting discipline that keeps a board confident between trial readouts.
Key Takeaways
- 1Board reporting should lead with runway, not just burn rate.
- 2Milestone-based financing requires financial models built around clinical timelines, not calendar quarters.
- 3Transparency about setbacks preserves more trust than optimistic framing.
About Elena Vasquez
Elena Vasquez is chief financial officer at Brightline Biotech, and joined Capital Founders Forum to discuss pharma / biotech and financial reporting within healthcare.
Never miss a conversation
New episodes on capital, growth, and exits — every two weeks.
Related Episodes
Healthcare
39 min
Medical practicesSuccessionFinancial reporting
The Economics of Physician-Owned Practices
What a physician-owned practice needs in its books two years before an owner plans to retire.
Sam Whitfield
Northgate Health Group
Healthcare
41 min
Patient operationsHealthcare M&AOperations
Fixing Patient Operations Before You Fix the P&L
The operating model mistake that shows up eighteen months after every hospital merger closes.
Maria Delgado
Continuum Health Partners